Can Orforglipron ACHIEVE the Unattainable?
First reports from the ACHIEVE-1 randomized controlled trial were presented during the American Diabetes Association 85th Scientific Sessions in Chicago and simultaneously published in The New England Journal of Medicine. ACHIEVE-1 explored the efficacy and safety of orforglipron in early T2D. As a general practitioner with a role in treating diabetes, I have been delighted to witness the evolution […]
Can Orforglipron ACHIEVE the Unattainable? Read More »
